FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387119006: Phenazopyridine hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461297013 Phenazopyridine hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481229011 Phenazopyridine hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
832591000172119 chlorhydrate de phénazopyridine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phenazopyridine hydrochloride (substance) Is a Phenazopyridine false Inferred relationship Some
Phenazopyridine hydrochloride (substance) Is a Pyridine and/or pyridine derivative true Inferred relationship Some
Phenazopyridine hydrochloride (substance) Is a allergène médicamenteux false Inferred relationship Some
Phenazopyridine hydrochloride (substance) Is a Non-opioid analgesic (substance) true Inferred relationship Some
Phenazopyridine hydrochloride (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Phenazopyridine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing phenazopyridine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 95 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 150 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 97.2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Product containing oxytetracycline hydrochloride and phenazopyridine hydrochloride and sulfamethizole The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some
Phenazopyridine hydrochloride 95 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 95 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 150 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 150 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 97.2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 97.2 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 3
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 3
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 97.2 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 95 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 1
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Phenazopyridine hydrochloride (substance) Inferred relationship Some 2
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Phenazopyridine hydrochloride (substance) Inferred relationship Some 2

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start